0001567619-20-004897.txt : 20200226 0001567619-20-004897.hdr.sgml : 20200226 20200226185856 ACCESSION NUMBER: 0001567619-20-004897 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200225 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van Elsas Andrea CENTRAL INDEX KEY: 0001714425 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 20657789 MAIL ADDRESS: STREET 1: KLOOSTERSTRAAT 9 CITY: OSS STATE: P7 ZIP: 5349 AB ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADURO BIOTECH, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 510-848-4400 MAIL ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 4 1 doc1.xml FORM 4 X0306 4 2020-02-25 0 0001435049 ADURO BIOTECH, INC. ADRO 0001714425 van Elsas Andrea KLOOSTERSTRAAT 9 OSS P7 5349 AB NETHERLANDS 0 1 0 0 Chief Scientific Officer Common Stock 2020-02-25 4 S 0 6823 3.5107 D 438367 D The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.37 to $3.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Celeste Ferber, Attorney-in-Fact for Andrea van Elsas 2020-02-26